(IN BRIEF) Merck, a prominent science and technology company, has revealed new findings from the MAVENCLAD® (cladribine tablets) MAGNIFY-MS study…
(IN BRIEF) Standard Chartered has updated its net zero roadmap and announced a target of a 29% reduction in absolute…